Synthesis and antifungal activity of some substituted phenothiazines and related compounds

European Journal of Medicinal Chemistry

Volumn 46, Issue 1, 2011, Pages 101-105

  Sarmiento, Gabriela P ^a   Vitale, Roxana G ^b,c,d   Afeltra, Javier ^a,c,d   Moltrasio, Graciela Y ^a   Moglioni, Albertina G ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

^d Facultad de Farmacia y Bioquímica Universidad de Buenos Aires ^*  (Argentina)

Author keywords

Antifungal activity; N acyl derivatives; Phenothiazines; Pipothiazine; Promethazine; Synthesis

Indexed keywords

10 (2 CHLOROETHYL) 10H PHENOTHIAZINE; 10 (3 CHLOROPROPIONYL) 10H PHENOTHIAZINE; 10 (3 CHLOROPROPIONYL) N,N DIMETHYL 10H PHENOTHIAZINE 2 SULFONAMIDE; 10 (3 CHLOROPROPYL ) 10H PHENOTHIAZINE; 10 (ACETYL) 10H PHENOTHIAZINE; 10 (CHLOROACETYL) 10H CARBAZOLE; 10 (CHLOROACETYL) 10H PHENOTHIAZINE; 10 (CHLOROACETYL) 10H PHENOXAZINE; 10 (CHLOROACETYL) N,N DIMETHYL 10H PHENOTHIAZINE 2 SULFONAMIDE; 2 (N CHLOROACETYLAMINE) 1 PHENYLTHIOBENZENE; 2 CHLORO N,N DIPHENYLACETAMIDE; PHENOTHIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTIFUNGAL AGENTS; DRUG DISCOVERY; FUNGI; MICROBIAL SENSITIVITY TESTS; PHENOTHIAZINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78650509773     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.10.019     Document Type: Article

References (29)

1. F.C. Odds Trends Microbiol. 8 2000 200 201
2. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss N. Engl. J. Med. 348 2003 1546 1554
3. M.B. Edmond, S.E. Wallace, D.K. McClish, M.A. Pfaller, R.N. Jones, and R.P. Wenzel Clin. Infect. Dis. 29 1999 239 244
4. M. Morrell, V.J. Fraser, and M.H. Kollef Antimicrob. Agents Chemother. 49 2005 3640 3645
5. K. Mühlemann, C. Wenger, R. Zenhaüsem, and M.G. Täuber Leukemia 19 2005 545 550
6. R.P. Rapp Pharmacotherapy 24 2004 4S 28S
7. M.K. El-Said Pharmazie 36 1981 678 679
8. R. Tilak, R. Tyagi, B. Goel, K.K. Saxena, V.K. Srivastava, and A. Kumar Indian Drugs 35 1998 216 221 Chem. Abstr. 129 (1998) 109052
9. J.N. Dominguez, S. Lopez, J. Charris, L. Iarruso, G. Lobo, A. Semenow, J.E. Olson, and P.J. Rosenthal J. Med. Chem. 40 1997 2726 2733
10. G. Lin, K.K. Midha, and E.M. Hawes J. Heterocycl. Chem. 28 1991 215 219
11. J. Raval, and K.K. Desai ARKIVOC xiii 2005 21 28
12. M. Viveros, and L. Amaral Int. J. Antimicrob. Agents 17 2001 225 228 Chem. Abstr. 134 (2001) 350521
13. A. Trivedi, A. Siddiqui, and V. Shah ARKIVOC ii 2008 210 217
14. N. Motohashi, M. Kawase, S. Saito, and H. Sakagami Curr. Drug Targets 1 2000 237 245 (Pub Med ID 11465073)
15. N. Motohashi, T. Kurihara, K. Satoh, H. Sakagami, I. Mucsi, R. Pusztai, and Molnar Anticancer Res. 19 1999 1837 1842
16. T. Kurihara, N. Motohashi, G.L. Pang, M. Higno, K. Kiguchi, and Molnar Anticancer Res. 16 1996 2757 2765
17. D. Ledincer, and L.A. Mitscher Organic Chemistry of Drug Synthesis vol. 1 1976 372-392
18. A.A. Borbely, and M. Loepfe-Hinkkanen Mod. Pharmacol. Toxicol. 16 1979 403 426
19. W.R. Reid, J.R. Wright, H.G. Kollofe, and J.H. Hunter J. Am. Chem. Soc. 70 1948 3100 3102
20. I. Meier Med. Monatsschr. 8 1954 397 399 Chem. Abstr. 48 (1954) 10225
21. R.G. Vitale, J. Afeltra, J.F.G.M. Meis, and P.E. Verweij Mycoses 50 2007 270 276
22. G.P. Sarmiento, G.Y. Moltrasio, and A.G. Moglioni ARKIVOC vii 2009 33 41
23. S. Darvesh, R.S. McDonald, A. Penwell, S. Conrad, K.V. Darvesh, D. Mataija, G. Gomez, A. Caines, R. Walsh, and E. Martin Bioorg. Med. Chem. 13 2005 211 213
24. J.P. Raval, and K.R. Desai ARKIVOC xiii 2005 21 28
25. L. Della Ciana, I. Hamachi, and T. Meyer J. Org. Chem. 54 1989 1731 1735
26. H.R. Howard, B.K. Koe, and A. Weissman J. Med. Chem. 32 1989 437 444
27. S.K. Srivastava, S.K. Nema, and A. Srivastava Ind. J. Chem. 47B 2008 606 612
28. National Committee for Clinical Laboratory Standards (2003). Reference method for broth dilution susceptibility testing of yeasts: approved standard. M27A2.
29. National Committee for Clinical Laboratory Standards (2008). Reference method for broth dilution susceptibility testing of filamentous fungi: approved standard. M38A2.